Shining the spotlight on your therapy area

This is a paid advertisement for SmartBrief readers.

The content does not necessarily reflect the view of SmartBrief or its Association partners.

If you are having trouble viewing this message in your e-mail client, please see the web version here

Shining the spotlight on your therapy area Spotlight On is a series of free reports by Thomson Reuters Cortellis™ Competitive Intelligence offering expert therapy area review of the key market players and deal highlights for leading areas of industry investment and development. This quarter's edition focuses on disease area Multiple Myeloma. It is the second most common hematological cancer worldwide, with an estimated 22,000 new cases and over 10,000 deaths expected in the U.S. in 2013 and an approximately equivalent incidence in Europe. This report shows that with the introduction of immunomodulatory agents significant progress in the last decade has extended survival. Sign up today to receive the full report on Multiple Myeloma and future issues of Spotlight On, direct to your desktop.     Download other Spotlight On issues Alzheimer's Disease Chronic Myeloid Leukemia Diabetes Hepatitis C Melanoma Non-Small-Cell Lung Cancer Obesity Personalized Medicine

About this email: BIO SmartBrief will occasionally send emails from our advertising partners promoting products and services determined to be of interest and relevance to our readers. Each email is carefully considered on a case-by-case basis. If you do not want to receive these emails, you can unsubscribe from them by clicking here. SmartBrief, Inc.® 555 11th ST NW, Suite 600, Washington, DC 20004